Provided by Tiger Fintech (Singapore) Pte. Ltd.

Black Diamond Therapeutics, Inc.

1.99
+0.270015.70%
Volume:16.35M
Turnover:31.52M
Market Cap:112.76M
PE:-1.57
High:2.05
Open:1.83
Low:1.75
Close:1.72
Loading ...

Wedbush Adjusts Black Diamond Therapeutics Price Target to $11 From $16, Maintains Outperform Rating

MT Newswires Live
·
07 Mar

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
07 Mar

Analysts Offer Insights on Healthcare Companies: Ventyx Biosciences (VTYX), Black Diamond Therapeutics (BDTX) and Passage Bio (PASG)

TIPRANKS
·
07 Mar

Black Diamond: Q4 Earnings Snapshot

Associated Press Finance
·
07 Mar

Black Diamond Therapeutic Q4 EPS $(0.28) Beats $(0.31) Estimate

Benzinga
·
07 Mar

Black Diamond Therapeutics Q4 Cash & Investments USD 98.6 Million

THOMSON REUTERS
·
07 Mar

Black Diamond Therapeutics Q4 Net Income USD -15.985 Million

THOMSON REUTERS
·
07 Mar

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire
·
07 Mar

Naya Biosciences Announces Nomination of New Board Members

THOMSON REUTERS
·
19 Feb

NAYA Biosciences Announces Nomination of New Board Members

GlobeNewswire
·
19 Feb

US Penny Stocks Spotlight: Information Services Group Among 3 Top Picks

Simply Wall St.
·
13 Dec 2024

Black Diamond Therapeutics Inc : Stifel Cuts Target Price to $16 From $18

THOMSON REUTERS
·
06 Nov 2024

Black Diamond Theraptcs Price Target Maintained With a $11.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Nov 2024

Promising Clinical Outcomes and Financial Stability Support Buy Rating for Black Diamond Therapeutics

TIPRANKS
·
06 Nov 2024

Strong Buy Rating for Black Diamond Therapeutics Driven by Financial Stability and Promising Clinical Developments

TIPRANKS
·
05 Nov 2024

Black Diamond: Q3 Earnings Snapshot

Associated Press Finance
·
05 Nov 2024